Source: International Congress 2015 – Lung cancer therapy: clinical trials
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Sebastian Thiel (Berlin, Germany), Sebastian Thiel, Daniel Misch, Crolow Catharina, Torsten Blum, Christian Boch, Jens Kollmeier, Torsten Bauer. Chemotherapy beyond 3rd line in NSCLC – A retrospective analysis. Eur Respir J 2015; 46: Suppl. 59, 4839

Member's Comments

No comment yet.

Related content which might interest you: The role of second line chemotherapy in small cell lung cancer: A retrospective analysis Source: Annual Congress 2013 –Advances in the therapy of lung cancer Year: 2013 ALK/EML4 translocation in non-squamous NSCLC and their predictors Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Progression vs. pseudo progression in the treatment of squamous NSCLC with nivolumab Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Surgical treatment outcomes on early-stages of non-small-cell lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Safety and efficacy of erlotinib in patients with squamous cell lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Predictors of lung cancer patients delay time in Serbia - a cross-sectional study Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Maintenance therapy with pemetrexed in non-small-cell lung cancer: Impact on survival Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Segmentectomy for second lung cancer after lobectomy Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 Improving survival for NSCLC patients in the national lung cancer audit Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Futile thoracotomy in lung cancer Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Survival in lung cancer: Associated factors in Tunisian patients Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015 Lung cancer in patients before the age of 45: A retrospective analysis of 62 patients Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015 Prognostic factors for survival in lung cancer Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Algorithm of preoperative N-staging of non-small cell lung cancer Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 A phase III randomised trial testing chemotherapy in extensive small-cell lung cancer (SCLC) Source: International Congress 2016 – Therapeutic trials in lung cancer Year: 2016 Treatment of advanced non-small cell lung cancer with trofosfamide Source: Annual Congress 2013 –Advances in the therapy of lung cancer Year: 2013 Metronomic chemotherapy in human lung cancer: Mathematical modeling for an optimal schedule Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Electrospray-mediated local chemotherapy of lung carcinoma in mice Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Diagnosing lung cancer: Choosing the best for your patient Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Lung cancer in women: What are particularities? Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014